SEARCH

SEARCH BY CITATION

References

  • Alegre, A., Tomas, J.F., Martinez-Chamorro, C., Gil-Fernandez, J.J., Fernandez-Villalta, M.J., Arranz, R., Diaz, M.A., Granda, A., Bernardo, M.R., Escudero, A., Lopez-Lorenzo, J.L. & Fernandez-Ranada, J.M. (1997) Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplantation, 20, 211217.
  • Anaissie, E.J., Vartivarian, S., Bodey, G.P., Legrand, C., Kantarjian, H., Abi-Said, D., Karl, C. & Vadhan-Raj, S. (1996) Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia. American Journal of Medicine, 100, 1723.
  • Arbona, C., Prosper, F., Benet, I., Mena, F., Solano, C. & Garcia-Conde, J. (1998) Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transplantation, 22, 3945.
  • Aviles, A., Diaz-Maqueo, J.C., Talavera, A., Nambo, M.J. & Garcia, E.L. (1994) Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy. Leukemia and Lymphoma, 15, 153157.
  • Bence-Bruckler, I., Bredeson, C., Atkins, H., McDiarmid, S., Hamelin, L., Hopkins, H., Perry, G., Genest, P. & Huebsch, L. (1998) A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation. Bone Marrow Transplantation, 22, 965969.
  • Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., Rowley, S., Demirer, T., Sanders, J., Storb, R. & Buckner, C.D. (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood, 85, 16551658.
  • Bensinger, W.I., Martin, P.J., Storer, B., Clift, R., Forman, S.J., Negrin, R., Kashyap, A., Flowers, M.E., Lilleby, K., Chauncey, T.R., Storb, R. & Appelbaum, F.R. (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. New England Journal of Medicine, 344, 175181.
  • Bernasconi, C., Alessandrino, E.P., Bernasconi, P., Bonfichi, M., Lazzarino, M., Canevari, A., Castelli, G., Brusamolino, E., Pagnucco, G. & Castagnola, C. (1998) Randomized clinical study comparing aggressive chemotherapy with or without G-CSF support for high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia evolving from MDS. British Journal of Haematology, 102, 678683.
  • Biesma, B., De Vries, E.G., Willemse, P.H., Sluiter, W.J., Postmus, P.E., Limburg, P.C., Stern, A.C. & Vellenga, E. (1990) Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever. European Journal of Cancer, 26, 932936.
  • Bishop, M.R., Anderson, J.R., Jackson, J.D., Bierman, P.J., Reed, E.C., Vose, J.M., Armitage, J.O., Warkentin, P.I. & Kessinger, A. (1994) High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood, 83, 610616.
  • Bishop, M.R., Tarantolo, S.R., Geller, R.B., Lynch, J.C., Bierman, P.J., Pavletic, Z.S., Vose, J.M., Kruse, S., Dix, S.P., Morris, M.E., Armitage, J.O. & Kessinger, A. (2000) A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood, 96, 8085.
  • Bjorkholm, M., Osby, E., Hagberg, H., Kvaloy, S., Teerenhovi, L., Myhre, J., Cavallin-Stahl, E., Holte, H. & Andersson, H. (1999) Randomised trial of r-metHu granulocyte colony stimulating factors as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma. Proceedings of the American Society of Hematology, 94, 599.
  • Blaise, D., Kuentz, M., Fortanier, C., Bourhis, J.H., Milpied, N., Sutton, L., Jouet, J.P., Attal, M., Bordigoni, P., Cahn, J.Y., Boiron, J.M., Schuller, M.P., Moatti, J.P. & Michallet, M. (2000) Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. Journal of Clinical Oncology, 18, 537546.
  • Bohlius, J., Reiser, M., Engert, A. & Group, C.H.M. (2001) Impact of prophylactic use of granulopoiesis-stimulating factors (G-CSF and GM-CSF) in patients with malignant lymphoma undergoing conventional chemotherapy: a comprehensive meta-analysis. Proceedings of the American Society of Hematology, 98, 346a.
  • Bolwell, B.J., Pohlman, B., Andresen, S., Kalaycio, M., Goormastic, M., Wise, K., Wakeling, A., Dannley, R. & Overmoyer, B. (1998) Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial. Bone Marrow Transplantation, 21, 369373.
  • Carella, A.M., Simonsson, B., Link, H., Lennard, A., Boogaerts, M., Gorin, N.C., Tomas-Martinez, J.F., Dabouz-Harrouche, F., Gautier, L. & Badri, N. (1998) Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha. British Journal of Haematology, 101, 111118.
  • Cesana, C., Carlo-Stella, C., Regazzi, E., Garau, D., Sammarelli, G., Caramatti, C., Tabilio, A., Mangoni, L. & Rizzoli, V. (1998) CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. Bone Marrow Transplantation, 21, 561568.
  • Chao, N.J., Schriber, J.R., Grimes, K., Long, G.D., Negrin, R.S., Raimondi, C.M., Horning, S.J., Brown, S.L., Miller, L. & Blume, K.G. (1993) Granulocyte colony-stimulating factor ‘mobilized’ peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood, 81, 20312035.
  • Clarke, V., Dunstan, F.D. & Webb, D.K. (1999) Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia. Medical Pediatric Oncology, 32, 331335.
  • Colby, C., McAfee, S.L., Finkelstein, D.M. & Spitzer, T.R. (1998) Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 21, 10051010.
  • Dickerson, K. & L.K. (1996) Optimal search strategy for RCTs. Establishing and maintaining an international register of RCTs. In: The Cochrane Library. Update Software, Oxford.
  • Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A. & Degos, L. (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. New England Journal of Medicine, 332, 16781683.
  • Dreger, P., Haferlach, T., Eckstein, V., Jacobs, S., Suttorp, M., Loffler, H., Muller-Ruchholtz, W. & Schmitz, N. (1994) G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. British Journal of Haematology, 87, 609613.
  • Dunlop, D.J., Eatock, M.M., Paul, J., Anderson, S., Reed, N.S., Soukop, M., Lucie, N., Fitzsimmons, E.J., Tansey, P. & Steward, W.P. (1998) Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group. Clinical Oncology (Royal College of Radiologists), 10, 107114.
  • Estey, E.H., Thall, P.F., Pierce, S., Cortes, J., Beran, M., Kantarjian, H., Keating, M.J., Andreeff, M. & Freireich, E. (1999) Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/− all-trans retinoic acid +/− granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Blood, 93, 24782484.
  • Faucher, C., Le Corroller, A.G., Blaise, D., Novakovitch, G., Manonni, P., Moatti, J.P. & Maraninchi, D. (1994) Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness. Bone Marrow Transplantation, 14, 895901.
  • Freund, D.A. & Dittus, R.S. (1995) Double-blind, placebo-controlled trial of daunorubicin and cytarabine with or without recombinant human granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: economic evaluation with attention to inpatient and outpatient resource utilization. Journal of the National Cancer Institute Monograph, 19, 3740 .
  • Fridrik, M.A., Greil, R., Hausmaninger, H., Krieger, O., Oppitz, P., Stoger, M., Klocker, J., Neubauer, M., Helm, W., Pont, J., Fazeny, B., Hudec, M., Simonitsch, I. & Radaszkiewicz, T. (1997) Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy. Annals of Hematology, 75, 135140.
  • Garcia-Carbonero, R., Mayordomo, J.I., Tornamira, M.V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., Tres, A., Perez-Gracia, J.L., Lumbreras, C., Hornedo, J., Cortes-Funes, H. & Paz-Ares, L. (2001) Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. Journal of the National Cancer Institute, 93, 3138.
  • Geissler, K., Koller, E., Hubmann, E., Niederwieser, D., Hinterberger, W., Geissler, D., Kyrle, P., Knobl, P., Pabinger, I., Thalhammer, R., Schwarzinger, I., Mannhalter, C., Jaeger, U., Heinz, R., Linkesch, W. & Lechner, K. (1997) Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia – a randomized phase-III study. Blood, 90, 590596.
  • Gerhartz, H.H., Engelhard, M., Meusers, P., Brittinger, G., Wilmanns, W., Schlimok, G., Mueller, P., Huhn, D., Musch, R., Siegert, W., Gerhartz, D., Hartlapp, J.H., Thiel, E., Huber, C., Peschl, C., Spann, W., Emmerich, B., Schadek, C., Westerhausen, M., Pees, H.W., Radtke, H., Engert, A., Terhardt, E., Schick, H., Binder, T., Fuchs, R., Hasford, J., Brandmaier, R., Stern, A.C., Jones, T.C., Ehrlich, H.J., Stein, H., Parwaresch, M., Tiemann, M. & Lennert, K. (1993) Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood, 82, 23292339.
  • Gisselbrecht, C., Haioun, C., Lepage, E., Bastion, Y., Tilly, H., Bosly, A., Dupriez, B., Marit, G., Herbrecht, R., Deconinck, E., Marolleau, J.P., Yver, A., Dabouz-Harrouche, F., Coiffier, B. & Reyes, F. (1997) Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte. Leukemia and Lymphoma, 25, 289300.
  • Godwin, J.E., Kopecky, K.J., Head, D.R., Willman, C.L., Leith, C.P., Hynes, H.E., Balcerzak, S.P. & Appelbaum, F.R. (1998) A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (9031). Blood, 91, 36073615.
  • Gustavsson, A. (1997) G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. Acta Oncologica, 36, 483488.
  • Hansen, P.B., Johnsen, H.E., Jensen, L., Gaarsdal, E., Simonsen, K. & Ralfkiaer, E. (1995) Priming and treatment with molgramostim (rhGM-CSF) in adult high-risk acute myeloid leukemia during induction chemotherapy: a prospective, randomized pilot study. European Journal of Haematology, 54, 296303.
  • Harousseau, J.L., Witz, B., Lioure, B., Hunault-Berger, M., Desablens, B., Delain, M., Guilhot, F., Le Prise, P.Y., Abgrall, J.F., Deconinck, E., Guyotat, D., Vilque, J.P., Casassus, P., Tournilhac, O., Audhuy, B. & Solary, E. (2000) Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques. Journal of Clinical Oncology, 18, 780787.
  • Hartmann, L.C., Tschetter, L.K., Habermann, T.M., Ebbert, L.P., Johnson, P.S., Mailliard, J.A., Levitt, R., Suman, V.J., Witzig, T.E., Wieand, H.S., Miller, L.L. & Moertel, C.G. (1997) Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. New England Journal of Medicine, 336, 17761780.
  • Heil, G., Hoelzer, D., Sanz, M.A., Lechner, K., Liu Yin, J.A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., Matcham, J. & Barge, A. (1997) A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood, 90, 47104718.
  • Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J.M., Winqvist, I., Oberg, G., Osterborg, A. & Ost, A. (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92, 6875.
  • Ho, A.D., Young, D., Maruyama, M., Corringham, R.E., Mason, J.R., Thompson, P., Grenier, K., Law, P., Terstappen, L.W. & Lane, T. (1996) Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Experimental Hematology, 24, 14601468.
  • Hohaus, S., Martin, H., Wassmann, B., Egerer, G., Haus, U., Farber, L., Burger, K.J., Goldschmidt, H., Hoelzer, D. & Haas, R. (1998) Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Bone Marrow Transplantation, 22, 625630.
  • Klumpp, T.R., Mangan, K.F., Goldberg, S.L., Pearlman, E.S. & Macdonald, J.S. (1995) Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. Journal of Clinical Oncology, 13, 13231327.
  • Kojima, S. (1999) Use of granulocyte colony-stimulating factor for treatment of aplastic anemia. Nagoya Journal of Medical Science, 62, 7782.
  • Kojima, S., Hibi, S., Kosaka, Y., Yamamoto, M., Tsuchida, M., Mugishima, H., Sugita, K., Yabe, H., Ohara, A. & Tsukimoto, I. (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood, 96, 20492054.
  • Korbling, M., Przepiorka, D., Huh, Y.O., Engel, H., Van Besien, K., Giralt, S., Andersson, B., Kleine, H.D., Seong, D., Deisseroth, A.B., Andreeff, M. & Champlin, R. (1995) Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood, 85, 16591665.
  • Kumar, M. & Alter, B.P. (1998) Hematopoietic growth factors for the treatment of aplastic anemia. Current Opinions in Hematology, 5, 226234.
  • Lamy, T., Drenou, B., Grulois, I., Leberre, C., Dauriac, C., Amiot, L., Godard, M., Fauchet, R. & LePrise, P.Y. (1994) Improvement of hematologic recovery after high-dose intensification using peripheral blood progenitor cells (PBPC) mobilized by chemotherapy and GM-CSF. Annals of Hematology, 69, 297302.
  • Larson, R.A., Dodge, R.K., Linker, C.A., Stone, R.M., Powell, B.L., Lee, E.J., Schulman, P., Davey, F.R., Frankel, S.R., Bloomfield, C.D., George, S.L. & Schiffer, C.A. (1998) A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia. CALGB Study 9111. Blood, 92, 15561564.
  • Laver, J., Amylon, M., Desai, S., Link, M., Schwenn, M., Mahmoud, H. & Shuster, J. (1998) Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study. Journal of Clinical Oncology, 16, 522526.
  • Lee, S.M., Radford, J.A., Dobson, L., Huq, T., Ryder, W.D., Pettengell, R., Morgenstern, G.R., Scarffe, J.H. & Crowther, D. (1998a) Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost. British Journal of Cancer, 77, 12941299.
  • Lee, S.J., Weller, E., Alyea, E.P., Ritz, J. & Soiffer, R.J. (1998b) Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation. Blood, 92, 27252729.
  • Legros, M., Fleury, J., Bay, J.O., Choufi, B., Basile, M., Condat, P., Glenat, C., Communal, Y., Tavernier, F., Bons, J.M., Chollet, P., Plagne, R. & Chassagne, J. (1997) rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial. Bone Marrow Transplantation, 19, 209213.
  • Lepage, E., Gisselbrecht, C., Haioun, C., Sebban, C., Tilly, H., Bosly, A., Morel, P., Herbrecht, R., Reyes, F. & Coiffier, B. (1993) Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA (Groupe d'Etude des Lymphomes de l'Adulte). Annals of Oncology, 4, 651656.
  • Linch, D.C., Milligan, D.W., Winfield, D.A., Kelsey, S.M., Johnson, S.A., Littlewood, T.J., Smith, G.M., Hutchinson, R.M., Goldstone, A.H., Fielding, A.K. & Vaughan Hudson, G. (1997) G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. British Journal of Haematology, 99, 933938.
  • Lowenberg, B., Boogaerts, M.A., Daenen, S.M., Verhoef, G.E., Hagenbeek, A., Vellenga, E., Ossenkoppele, G.J., Huijgens, P.C., Verdonck, L.F., Van Der Lelie, J., Wielenga, J.J., Schouten, H.C., Gmur, J., Gratwohl, A., Hess, U., Fey, M.F. & Van Putten, W.L. (1997a) Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. Journal of Clinical Oncology, 15, 34963506.
  • Lowenberg, B., Suciu, S., Archimbaud, E., Ossenkoppele, G., Verhoef, G.E., Vellenga, E., Wijermans, P., Berneman, Z., Dekker, A.W., Stryckmans, P., Schouten, H., Jehn, U., Muus, P., Sonneveld, P., Dardenne, M. & Zittoun, R. (1997b) Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group. Blood, 90, 29522961.
  • Maher, D.W., Lieschke, G.J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., Sheridan, W.P., Kefford, R.F., Cebon, J., Olver, I., McKendrick, J., Toner, G., Bradstock, K., Lieschke, M., Cruickshank, S., Tomita, D.K., Hoffman, E.W., Fox, R.M. & Morstyn, G. (1994) Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 121, 492501.
  • Marsh, J.C. (2000) Hematopoietic growth factors in the pathogenesis and for the treatment of aplastic anemia. Seminars in Hematology, 37, 8190.
  • Mayordomo, J.I., Rivera, F., Diaz-Puente, M.T., Lianes, P., Colomer, R., Lopez-Brea, M., Lopez, E., Paz-Ares, L., Hitt, R., Garcia-Ribas, I., Cubedo, R., Alonso, S. & Cortesfunes, H. (1995) Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. Journal of the National Cancer Institute, 87, 803808.
  • Meisenberg, B., Brehm, T., Schmeckel, A., Miller, W. & McMillan, R. (1998) A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells. Transfusion, 38, 209215.
  • Michel, G., Landman-Parker, J., Auclerc, M.F., Mathey, C., Leblanc, T., Legall, E., Bordigoni, P., Lamagnere, J.P., Demeocq, F., Perel, Y., Auvrignon, A., Berthou, C., Bauduer, F., Pautard, B., Schneider, P., Schaison, G., Leverger, G. & Baruchel, A. (2000) Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 18, 15171524.
  • Mitchell, P.L., Morland, B., Stevens, M.C., Dick, G., Easlea, D., Meyer, L.C. & Pinkerton, C.R. (1997) Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients. Journal of Clinical Oncology, 15, 11631170.
  • Nademanee, A., Sniecinski, I., Schmidt, G.M., Dagis, A.C., O'Donnell, M.R., Snyder, D.S., Parker, P.M., Stein, A.S., Smith, E.P., Molina, A., Stepan, D.E., Somlo, G., Margolin, K.A., Woo, D., Niland, J.C. & Forman, S.J. (1994) High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Journal of Clinical Oncology, 12, 21762186.
  • Ohno, R., Naoe, T., Kanamaru, A., Yoshida, M., Hiraoka, A., Kobayashi, T., Ueda, T., Minami, S., Morishima, Y., Saito, Y., Furusawa, S., Imai, K., Takemoto, Y., Miura, Y., Teshima, H. & Hamajima, N. (1994) A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group. Blood, 83, 20862092.
  • Ossenkoppele, G.J., Van Der Holt, B., Verhoef, G.E., Daenen, S.M., Verdonck, L.F., Sonneveld, P., Wijermans, P.W., Van Der Lelie, J., Van Putten, W.L. & Lowenberg, B. (1999) A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative Group. Leukemia, 13, 12071213.
  • Ottmann, O.G., Hoelzer, D., Gracien, E., Ganser, A., Kelly, K., Reutzel, R., Lipp, T., Busch, F.W., Schwonzen, M., Heil, G., Wandt, H., Koch, P., Kolbe, K., Heyll, A., Bentz, M., Peters, S.D., Iedrich, H., Dethling, J., Meyer, P., Nowrousian, M.R., Loffler, B., Weiss, A., Kneba, M., Foller, A., Graf, M. & Hecht, T. (1995) Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood, 86, 444450.
  • Ozer, H., Armitage, J.O., Bennett, C.L., Crawford, J., Demetri, G.D., Pizzo, P.A., Schiffer, C.A., Smith, T.J., Somlo, G., Wade, J.C., Wade, J.L., 3rd, Winn, R.J. & Wozniak, A.J. & Somerfield, M.R. (2000) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. Journal of Clinical Oncology, 18, 35583585.
  • Pavletic, Z.S., Bishop, M.R., Tarantolo, S.R., Martin-Algarra, S., Bierman, P.J., Vose, J.M., Reed, E.C., Gross, T.G., Kollath, J., Nasrati, K., Jackson, J.D., Armitage, J.O. & Kessinger, A. (1997) Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. Journal of Clinical Oncology, 15, 16081616.
  • Pettengell, R., Gurney, H., Radford, J.A., Deakin, D.P., James, R., Wilkinson, P.M., Kane, K., Bentley, J. & Crowther, D. (1992) Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood, 80, 14301436.
  • Pfreundschuh, M., Trumper, L., Kloess, M., Schmitz, N., Schmits, R., Glass, B., Hansenclever, D., Engert, A., Rudolph, C., Illiger, J., Hossfeld, D., Rube, C. & Loeffler, M. (2001) 2 weekly CHOP (CHOP14): the new standard regimen for patients with aggressive non-Hodgkin's lymphoma (NHL) > 60 years of age. Proceedings of the American Society of Hematology, 98, 725a.
  • Pui, C.H., Boyett, J.M., Hughes, W.T., Rivera, G.K., Hancock, M.L., Sandlund, J.T., Synold, T., Relling, M.V., Ribeiro, R.C., Crist, W.M. & Evans, W.E. (1997) Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. New England Journal of Medicine, 336, 17811787.
  • Ravaud, A., Chevreau, C., Cany, L., Houyau, P., Dohollou, N., Roche, H., Soubeyran, P., Bonichon, F., Mihura, J., Eghbali, H., Tabah, I. & Bui, B.N. (1998) Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial. Journal of Clinical Oncology, 16, 29302936.
  • Riikonen, P., Saarinen, U.M., Makipernaa, A., Hovi, L., Komulainen, A., Pihkala, J. & Jalanko, H. (1994) Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatrics Infection and Disease Journal, 13, 197202.
  • Rowe, J.M., Andersen, J.W., Mazza, J.J., Bennett, J.M., Paietta, E., Hayes, F.A., Oette, D., Cassileth, P.A., Stadtmauer, E.A. & Wiernik, P.H. (1995) A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55–70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood, 86, 457462.
  • Schiffer, C.A. (1996) Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia. Blood, 88, 36753685.
  • Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E.B., Haferlach, T., Loffler, H., Hunter, A. & Russell, N.H. (1995a) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood, 85, 16661672.
  • Schmitz, N., Dreger, P., Zander, A.R., Ehninger, G., Wandt, H., Fauser, A.A., Kolb, H.J., Zumsprekel, A., Martin, A. & Hecht, T. (1995b) Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Bone Marrow Transplantation, 15, 261266.
  • Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M., Link, H., Zander, A. & Barge, A. (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347, 353357.
  • Schmitz, N., Bacigalupo, A., Hasenclever, D., Nagler, A., Gluckman, E., Clark, P., Bourquelot, P., Greinix, H., Frickhofen, N., Ringden, O., Zander, A., Apperley, J.F., Gorin, C., Borkett, K., Schwab, G., Goebel, M., Russell, N.H. & Gratwohl, A. (1998) Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 21, 9951003.
  • Shinohara, K. (2000) Overuse of granulocyte colony-stimulating factor in acute myeloid leukemia, aplastic anemia and myelodysplastic syndrome. Internal Medicine, 39, 82.
  • Stone, R.M., Berg, D.T., George, S.L., Dodge, R.K., Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B.L. & Schiffer, C.A. (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. New England Journal of Medicine, 332, 16711677.
  • Storek, J., Gooley, T., Siadak, M., Bensinger, W.I., Maloney, D.G., Chauncey, T.R., Flowers, M., Sullivan, K.M., Witherspoon, R.P., Rowley, S.D., Hansen, J.A., Storb, R. & Appelbaum, F.R. (1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood, 90, 47054709.
  • Sweetenham, J., Hackshaw, A. & Knight, A. (2000) Evidence-based review and meta-analysis of the use of haemopoietic growth factors (HGFs) in the management of malignant lymphoma (ML). Proceedings of the American Society of Hematology, 96, 139a.
  • Takeshita, A., Ohno, R., Hirashima, K., Toyama, K., Okuma, M., Saito, H., Ikeda, Y., Tomonaga, M. & Asano, S. (1995) [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia (rG.CSF clinical study group)]. Rinsho Ketsueki, 36, 606614.
  • Tarella, C., Castellino, C., Locatelli, F., Caracciolo, D., Corradini, P., Falda, M., Novarino, A., Tassi, V. & Pileri, A. (1998) G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs. Bone Marrow Transplantation, 21, 401407.
  • Thomas, X., Fenaux, P., Dombret, H., Delair, S., Dreyfus, F., Tilly, H., Vekhoff, A., Cony-Makhoul, P., Leblond, V., Troussard, X., Cordonnier, C., De Revel, T., Simon, M., Nicolini, F., Stoppa, A.M., Janvier, M., Bordessoule, D., Rousselot, P., Ffrench, M., Marie, J.P. & Archimbaud, E. (1999) Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial). Leukemia, 13, 12141220.
  • Thompson, J.A., Gilliland, D.G., Prchal, J.T., Bennett, J.M., Larholt, K., Nelson, R.A., Rose, E.H. & Dugan, M.H. (2000) Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group. Blood, 95, 11751179.
  • Usuki, K., Urabe, A., Masaoka, T., Ohno, R., Mizoguchi, H., Hamajima, N., Miyazaki, T., Niitsu, Y., Yoshida, Y., Miura, A., Shibata, A., Abe, T., Miura, Y., Ikeda, Y., Nomura, T., Nagao, T., Saitou, H., Shirakawa, S., Ohkuma, M., Matsuda, T., Nakamura, T., Horiuchi, A., Kuramoto, A., Kimura, I., Irino, S., Niho, Y., Takatsuki, K., Tomonaga, M., Uchino, H. & Takaku, F. (2002) Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study. British Journal of Haematology, 116, 103112.
  • Uyl-de Groot, C.A., Lowenberg, B., Vellenga, E., Suciu, S., Willemze, R. & Rutten, F.F. (1998) Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia. British Journal of Haematology, 100, 629636.
  • Vellenga, E., Uyl-de Groot, C.A., De Wit, R., Keizer, H.J., Lowenberg, B., Ten Haaft, M.A., De Witte, T.J., Verhagen, C.A., Stoter, G.J., Rutten, F.F., Mulder, N.H., Smid, W.M. & De Vries, E.G. (1996) Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. Journal of Clinical Oncology, 14, 619627.
  • Welte, K., Reiter, A., Mempel, K., Pfetsch, M., Schwab, G., Schrappe, M. & Riehm, H. (1996) A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group. Blood, 87, 31433150.
  • Willemze, R., Van Der Lely, N., Zwierzina, H., Suciu, S., Solbu, G., Gerhartz, H., Labar, B., Visani, G., Peetermans, M.E., Jacobs, A., Stryckmans, P., Fenaux, P., Haak, H.L., Ribeiro, M.M., Baumelou, E., Baccarani, M., Mandelli, F., Jaksic, B., Louwagie, A., Thyss, A., Hayat, M., De Cataldo, F., Stern, A.C. & Zittoun, R. (1992) A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative Group. Annals of Hematology, 64, 173180.
  • Witz, F., Sadoun, A., Perrin, M.C., Berthou, C., Briere, J., Cahn, J.Y., Lioure, B., Witz, B., Francois, S., Desablens, B., Pignon, B., Le Prise, P.Y., Audhuy, B., Caillot, D., Casassus, P., Delain, M., Christian, B., Tellier, Z., Polin, V., Hurteloup, P. & Harousseau, J.L. (1998) A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood, 91, 27222730.
  • Yoshida, Y., Nakahata, T., Shibata, A., Takahashi, M., Moriyama, Y., Kaku, K., Masaoka, T., Kaneko, T. & Miwa, S. (1995) Effects of long-term treatment with recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome. Leukemia and Lymphoma, 18, 457463.
  • Zinzani, P.L., Pavone, E., Storti, S., Moretti, L., Fattori, P.P., Guardigni, L., Falini, B., Gobbi, M., Gentilini, P., Lauta, V.M., Bendandi, M., Gherlinzoni, F., Magagnoli, M., Venturi, S., Aitini, E., Tabanelli, M., Leone, G., Liso, V. & Tura, S. (1997) Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood, 89, 39743979.
  • Zittoun, R., Suciu, S., Mandelli, F., De Witte, T., Thaler, J., Stryckmans, P., Hayat, M., Peetermans, M., Cadiou, M., Solbu, G., Petti, M.C. & Willemze, R. (1996) Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. Journal of Clinical Oncology, 14, 21502159.